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Salvia sclareoides is an aromatic herb native to Portugal, of which phenolic content (Folin–Ciocalteau
method), chemical proﬁle (HPLC/DAD), antioxidant activity (DPPH, b-carotene/linoleic acid assays), acute
toxicity (MTT method, adapted for non-adherent cells), genotoxicity (short-term chromosomal aberra-
tion assay) and prion binding properties were evaluated in the acetone, water, ethanol, methanol and
n-butanol extracts. The latter presented the highest phenolic content and antioxidant activity (DPPH
assay), and was the single one with the ﬂavonoids (+)-catechin, kaempferol O-glucoside and quercetin.
Vanillic acid was the major component of all extracts but gallic, gentisic, caffeic, syringic, coumaric
and ferulic acids were also found in some extracts. Only the n-butanol extract had components binding
to the cellular form of human prion protein detected by NMR which showed speciﬁcity for two regions of
the folded domain and for the unstructured N-terminal region. Extracts were not cytotoxic nor genotoxic,
reinforcing the potential of S. sclareoides for nutraceutical purposes.
 2011 Elsevier Ltd. All rights reserved.1. Introduction
Salvia is one of the largest genera of the Lamiaceae family and is
widespread in the Mediterranean region, South-East Asia and Cen-
tral America. Salvia species are reputed for their medicinal proper-
ties and they have been used in folk medicine to treat colds,
wounds and skin infections, headache, cerebral ischaemia and
memory disorders (Kivrak et al., 2009), as well as hepatitis (Jin,
Quian, & Lu, 2011). Sage (Salvia ofﬁcinalis) is cultivated in Europe
and used as a culinary condiment and a food additive, and in tradi-
tional medicine for its antiseptic, astringent and spasmolytic ef-
fects. Spanish sage (Salvia lavandulaefolia Vahl.) and sage have
also been used against memory loss in European folk medicine
(Howes, Perry, & Houghton, 2003). In traditional Chinese medicine
neurological pathologies, such as insomnia, are treated with Salvia
miltiorrhiza Bge., which also decreases the intake of alcohol in vivo
(Carai et al., 2000).
It is well established that oxidative stress, which results from
the presence of excessive quantities of reactive oxygen species in
biological systems, may cause cell membrane dysfunction andll rights reserved.
: +351 217500088.DNA damage. Many degenerative disorders, namely cardiovascular
and brain diseases, arthritis, diabetes, cancer and immune system
decline involve cellular damage possibly caused by free radicals.
Antioxidant compounds play a crucial role in the treatment of
these pathologies by acting as free radical scavengers, thus
decreasing the extent of oxidative damage. Hence, evaluation of
radical scavenging properties and antioxidant activity is relevant
with plants claimed to have medicinal applications. A variety of
Salvia species were reported to have promising radical scavenging
activities, namely S. ofﬁcinalis (Oboh & Hente, 2009), Turkish (Senol
et al., 2010) and South African (Kamatou, Viljoen, & Steenkamp,
2010) species.
The antioxidant activity of Salvia species extracts has been re-
lated to their total phenolic content in a direct manner: extracts
rich in polyphenols (mainly phenolic acids and ﬂavonoids) usually
have a higher antioxidant capacity (Tosun et al., 2009). Phenolic
acids with antioxidant activity have been isolated from the extracts
of the traditional Chinese herb S. miltiorrhiza (Zhao et al., 2011).
These polyphenols acting as free radical scavengers have shown
beneﬁcial health-promoting effects in chronic and degenerative
diseases. Some of them inhibit amyloid ﬁbril formation and a
newmechanism of action for these antioxidants has been proposed
by Porat, Abramowitz, and Gazit (2006), based on structural con-
straints and speciﬁc aromatic interactions, which direct
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tannic acid, katacine and 2,2-bisepigallocatechin digallate were
also studied against prion PrPSc (the infectious form of prion pro-
tein) and proved to inhibit the formation of ﬁbrillar assemblies at
the lM range (Porat et al., 2006).
More than 20 amyloid-related diseases, including type II diabe-
tes, familial amyloidosis, Alzheimer’s, Parkinson’s, Huntington’s
and prion diseases are known, but therapeutical solutions for most
of them are missing, which encourages chemists and biologists to
further study polyphenols and their neuroprotective effects.
The subject of the present study is Salvia sclareoides, a species
native to Portugal which exhibits a potent cholinesterase inhibi-
tory activity (Rauter et al., 2007) of relevance to memory dysfunc-
tion and Alzheimer’s disease. Extracts induced a signiﬁcant
inhibition of acetylcholinesterase, even at the concentration of
10 lg/ml, while the standard drug rivastigmine did not inhibit
the enzyme at the same concentration. In addition, extracts from
S. sclareoides were found to retard the rate of prion propagation
in a cell-based screen (Martins et al., 2009). Herein, extracts from
S. sclareoides are investigated with the following objectives:
(i) To search for functional food ingredients from S. sclareoides;
(ii) To determine the phenolic proﬁle of S. sclareoides extracts
obtained with solvents of different polarity;
(iii) To evaluate the antioxidant activity;
(iv) To evaluate the direct cytotoxicity and genotoxicity;
(v) To evaluate whether the extracts interact with human prion
protein;
(vi) To demonstrate S. sclareoides beneﬁts for nutraceutical and
medicinal purposes.
2. Experimental
2.1. Plant material and extracts preparation
Aerial parts of S. sclareoides Brot. (Labiatae), collected at the Liz-
andro Estuary, Mafra, Portugal in May, were identiﬁed in the Her-
barium João Carvalho Vasconcelos (LISI), Instituto Superior de
Agronomia, Universidade Técnica de Lisboa, Portugal, where a vou-
cher specimen was deposited. The air-dried and ﬁnely powdered
aerial parts (280 g) of the plant were macerated overnight, in ace-
tone, at room temperature (rt). The macerate was then ﬁltered and
concentrated to dryness, at 40 C, under reduced pressure to give
the acetone extract (11 g). The same procedure was performed to
obtain the ethanol extract (3 g). The n-butanol and water extracts
were prepared as follows: the aerial parts (100 g) were extracted
ﬁrstly with dichloromethane at rt and solvent evaporation under
reduced pressure, at 40 C, gave the dichloromethane extract
(2 g). The plant was then extracted with methanol to give, after
evaporation of the solvent, the methanol extract (5 g). The last
extraction was made with a 50% methanol aqueous solution. Meth-
anol was evaporated and the aqueous phase was extracted with n-
butanol, to give the butanolic extract (3 g). Finally, the aqueous
phase was concentrated to dryness to give the water extract (8 g).
2.2. Determination of total phenolics
The content of phenolic compounds in S. sclareoides extracts
was determined using Folin–Ciocalteau reagent (Miliauskas, Vens-
kutonis, & Van Beek, 2004). For the preparation of the calibration
curve, 20 ll aliquots of 0.024, 0.075, 0.105, 0.15 and 0.18 mg/ml
gallic acid solution in water were mixed with 100 ll of tenfold
water diluted Folin–Ciocalteau reagent and 80 ll of 7.5% (w/v)
sodium carbonate solution. After 30 min at rt, the absorbance
was measured at 765 nm on a UV/visible light spectrophotometer
Shimadzu and the calibration curve was drawn. For thedetermination of plant extracts phenolic content, 20 ll of extract
solution was mixed with the same reagents as described above,
and after 1 h the absorption was measured. The experiment was
carried out in triplicate. Total content of phenolic compounds in
S. sclareoides extracts, expressed as gallic acid equivalents (GAE),
was calculated as follows:
C ¼ ðc  VÞ=m;
where C – total phenol content (mg GAE/g plant extract); c – con-
centration of gallic acid established from the calibration curve
(mg GA/ml); V – volume of gallic acid/Salvia extract solution
(=0.02 ml); m – weight of pure plant dry extract (g).
2.3. HPLC–DAD analysis
HPLC grade methanol (MeOH, 99.9%) was purchased from
Merck (Darmstadt, Germany) and acetic acid (99.8%) from Riedel-
de Haën (Seelze, Germany). Ferulic acid (trans-4-hydroxy-3-meth-
oxycinnamic acid, 99%), caffeic acid (3,4-dihydroxycinnamic acid,
97% predominantly trans), syringic acid (4-hydroxy-3,5-dimeth-
oxybenzoic acid, 98%), gallic acid (3,4,5-trihydroxybenzoic acid,
97%), gentisic acid (2,5-dihydroxybenzoic acid, 98%), coumaric acid
(trans-4-hydroxycinnamic acid, 98%), vanillic acid (4-hydroxy-3-
methoxybenzoic acid, 97%), (+)-catechin hydrate [(2R,3S)-2-(3,4-
dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol, 98%],
rutin hydrate (95%) and quercetin dehydrate (98%) were purchased
from Sigma–Aldrich (Buchs, Germany). Chlorogenic acid [1,3,4,5-
tetrahydroxycyclohexanecarboxylic acid 3-(3,4-dihydroxycin-
namate), P95%], and kaempferol 3-O-glucoside (P99%) were
purchased from Extrasynthèse (Genay, France). Ultra-pure water
was obtained from Milli-Q water puriﬁcation systems (Millipore,
Palm Springs, CA, USA). The stock solutions of individual standards
(1000 mg l1) and samples were prepared in HPLC grade MeOH
and used to prepare the working standard mixtures at the desired
concentration. After experimental procedures, the stock solutions
and working standards were wrapped in aluminium foil and stored
at 4 C to prevent photodegradation.
HPLC–DAD analyses were carried out on an Agilent 1100 Series
LC system (Agilent Technologies, Waldbronn, Germany), composed
by the following modules: vacuum degasser (G1322A), quaternary
pump (G1311A), autosampler (G1313A), thermostatted column
compartment (G1316A) and the diode array detector (G1315B).
The data acquisition and instrumental control were performed by
the software LC3D ChemStation (version Rev.A.10.0 [1757], Agilent
Technologies). Analyses were performed on a Mediterranean Sea 18
column, 150  2.1 mm, 5 lm particle size (Teknokroma, Barcelona,
Spain). The mobile phase consisted on a mixture of MeOH (solvent
A) and 2.5% acetic acid aqueous solution (solvent B). The applied
gradient was 0–50 min: 30–80% A, 50–55 min: 80–30% A and hold
at 30% A for 5 min and the ﬂow rate was 0.5 ml min1. The analyses
were performed at 25 C and the injection volume was 10 ll with a
draw speed of 200 ll min1. The detector was set at 280 nm. For
identiﬁcation purposes, the retention parameters of each extract
were compared with the standard controls and the peak purity
with the UV–visible spectral reference data.
2.4. Antioxidant activity
The antioxidant potential of S. sclareoides extracts (n-butanol,
ethanol, methanol, acetone and water), was assessed by two spec-
trophotometric methods: 2,2-diphenyl-1-picrylhydrazyl hydrate
(DPPH) free radical scavenging activity and b-carotene/linoleic acid
bleaching assay. Tests were carried out with extracts and reference
antioxidants: the synthetic butylated hydroxytoluene (BHT) and
the natural antioxidant, ascorbic acid (AA), in concentrations
ranging from 1 to 500 lg/ml. A blank sample consisting of the
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tract, BHT or ascorbic acid was also carried out. The reagents (p.a.)
DPPH, b-carotene, linoleic acid, Tween 40, DMSO, methanol, chlo-
roform, ascorbic acid and BHT were purchased from Sigma–Aldrich
(Buchs, Switzerland). After performing the activity experiments,
each extract/control concentration causing 50% antioxidant activ-
ity (IC50) for both methods used, was estimated by mathematical
regression from a dose–response curve.2.4.1. DPPH free radical scavenging assay
The DPPH radical scavenging activity of S. sclareoides extracts
was measured according to Özgen et al (2006), with slight modiﬁ-
cations. The DPPH test is based on the ability of the extracts to do-
nate a radical hydrogen to scavenge the stable DPPH radical. When
this radical reacts with the antioxidant compound, it is reduced
with the loss of the deep violet colour to light-yellow. The absor-
bance was measured at 517 nm on a visible light spectrophotometer
Shimadzu. Each S. sclareoides extract (20 mg) was dissolved in
methanol (1 ml), with the exception of the water extract, which
was dissolved in ultra-pure water. DPPH solution in methanol
(0.27 mM) was prepared daily, before absorbance measurements,
and to this solution (185 ll), kept in appropriate disposable plastic
cuvettes (Plastibrand), the extract solution (15 ll) was added and
the mixture shaken vigorously. Final extract concentration ranged
from 1 to 500 lg/ml, whereas DPPH solution was 0.25 mM. After
30 min incubation in the dark at rt, absorbance at 517 nm was
measured. The experiment was carried out in triplicate. Reference
synthetic antioxidant BHT (dissolved in methanol) and natural
antioxidant ascorbic acid (dissolved in water) were also tested in
the same concentrations of S. sclareoides extracts for comparison
purposes. A blank sample consisting of the same reagent mixture
and experimental procedure but without extract, BHT or ascorbic
acid was always carried out. The %DPPH radical scavenging activity
was calculated as follows:
DPPH radical scavenging effect ð%Þ
¼ ½ðAbsblank  AbsextractÞ=Absblank  100;
where Absblank is the absorbance of the blank sample (time = 30
min) and Absextract is the absorbance of the sample with the plant
extract (time = 30 min).2.4.2. b-Carotene/linoleic acid bleaching assay
The b-carotene bleaching test estimates the capacity of a plant
extract solution to inhibit b-carotene oxidation in the presence of
linoleic acid in pro-oxidation conditions. The acetone, n-butanol,
ethanol, methanol extracts of S. sclareoides and BHT were solubi-
lised in DMSO, whereas plant water extract and ascorbic acid solu-
tions were prepared with distilled water. The antioxidant activity
of S. sclareoides extracts using the b-carotene/linoleic acid assay
was measured according to Miller (1971) with minor modiﬁca-
tions. Brieﬂy, a stock solution of b-carotene/linoleic acid mixture
was prepared as follows: b-carotene (0.2 mg) was dissolved in
chloroform (1 ml) and then linoleic acid (22 ll) and Tween 40
(200 mg) were added. Chloroform was completely evaporated
using a vacuum evaporator. Then, distilled water saturated with
oxygen (40 ml) was added under vigorous shaking. The reaction
mixture (2 ml) was dispensed into test tubes, and each plant ex-
tract solution (0.5 ml) was added. The mixture containing the plant
extract or the control antioxidants was incubated at 50 C for 2 h
and absorbances were acquired along the incubation period at
470 nm. BHT and ascorbic acid were used as standards. The exper-
iments were carried out in duplicate. The ﬁnal concentrations of
chemicals in the test were as follows:[b-Carotene] = 4 lg/ml; [Linoleic acid] = 400 lg/ml; [Salvia ex-
tract] = 1–500 lg/ml. The antioxidant activity (AA) was calculated
from the oxidation rates (R) as follows:
Ln (Abs) = ln (Abs0) + R  t, where R, the bleaching rate, is the
slope of ln (Abs) vs. time line, which can be calculated by linear
regression, being t the time in minutes.
AA (%) = [(Rblank  Rextract)/Rblank]  100, where Rblank and Rextract
are the oxidation rates of blank sample and sample containing the
extract, respectively.2.5. Toxicity studies
Acute toxicity assessment was performed by the MTT method
adapted for non-adherent cells (Young, Phungtamdet, & Sanderson,
2005). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay was performed to quantify metabolically via-
ble cells in all samples. Suspension cells (K562 human erythroblas-
toid cell line) were seeded onto 96-well plates, allowed to divide
for 24 h and exposed to the test compounds for the following
24 h. Positive controls (hydrogen peroxide) and negative controls
(pure solvent) were also included. After 48 h of culture, MTT was
added to the cells at a ﬁnal concentration of 0.5 mg/ml, followed
by an incubation period of 3 h to allow the formazan crystals to
form. After the incubation time, DMSO (100 ll) was added to each
well. Solubilisation of formazan crystals was performed by agita-
tion in a 96-well plate shaker for 20 min at rt. Absorbance of each
well was quantiﬁed at 550 nm using 620 nm as reference wave-
length on a scanning multiwell spectrophotometer (automated
plate reader). Genotoxicity was assessed by the short-term
in vitro chromosomal aberration assay according to Rueff et al.
(1993). Brieﬂy, cell cultures of peripheral blood lymphocytes from
healthy donors were set up, and lymphoproliferation was induced
with phytohemagglutinnin (2% v/v, 24 h incubation). Cells were
exposed to the plant extracts for 24 h, and then colcemid, at a ﬁnal
concentration of 0.5 lg/ml, was added during the last 3 h of cul-
ture, to stop the dividing cells in the metaphase stage of mitosis.
Metaphase spreads were obtained in standard glass microscopy
slides, pre-washed and covered with a thin water ﬁlm. Scoring
was performed in a Zeiss optical microscope at 1250 magniﬁca-
tion, by observing 100 complete metaphases (presenting 46 centr-
omers) per case. Classiﬁcation of chromosomal aberrations was
done according to criteria described by Rueff et al. (1993). The mi-
totic index was also quantiﬁed by counting the number of meta-
phases per 1000 nuclei.2.6. Interaction with human prion protein
S. sclareoides acetone, methanol, ethanol, n-butanol and water
extracts were dissolved in d6-DMSO at approximately 100 mg/ml.
NMR samples (0.5 ml) were prepared through the addition of the
extract solutions (to a ﬁnal concentration of approximately 1 mg/
ml) to a solution containing 100 lM uniformly 15N-labelled human
prion protein (residues 91–231; huPrP91–231) at pH 5.5 in 20 mM
sodium acetate, 0.02% sodium azide, 10% D2O and 10% d6-DMSO.
NMR spectra were acquired at 298 K on a Bruker DRX-800 spec-
trometer equipped with a 5 mm 13C/15N/1H triple-resonance
probe. Proton chemical shifts were referenced to 1 mM TSP added
to the samples. 15N chemical shifts were calculated relative to TSP,
using the gyromagnetic ratios of 15N and 1H (15N/1H 0.101329118).
NMR data were processed and analysed on Linux Workstations
using Felix 2007 (Accelrys, San Diego, CA) software. 15N-HSQC
spectra of the huPrP91–231–salvia extract samples were analysed
for perturbation of huPrP91–231 resonances relative to control sam-
ples, in which the extracts were omitted. Intensity changes of
huPrP91–231 resonances were displayed on the 3D structure of
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age loss of resonance intensity.3. Results and discussion
3.1. Chemical analysis
The total phenolic content (TPC) of each extract was ﬁrst deter-
mined. The n-butanol extract had the highest TPC value
(379 mg GAE/g dry extract), while the lowest one (22 mg GAE/
g dry extract) was exhibited by the water extract (Table 1).
Moreover, TPC of the S. sclareoides n-butanol extract was higher
than those reported for South African Salvia species (45.6–212
mg GAE/g dry extract) (Kamatou et al., 2010) and for the Turkish
plant Salvia fruticosa, where a TPC of 87.9 mg GAE/g dry extract
was given for a dichloromethane extract (Senol et al., 2010). The
TPC of S. sclareoides is, however, consistent with the one reported
for the ethanolic extract of Salvia juduica (380.5 mg GAE/g dry ex-
tract) evaluated by the Folin Dennis method (Al-Ismail, Herzallah,
& Rustom, 2007).
The chemical proﬁle was determined by HPLC–DAD. Optimisa-
tion of the system was performed in order to achieve convenient
instrumental conditions to analyse the standard phenolic com-
pounds (Table 1). Preliminary assays indicated that all the 12 stan-
dards resolve in a suitable analytical time. Subsequently, acetone,
ethanol, methanol and n-butanol extracts of S. sclareoides were
analysed under the same instrumental conditions, but the water
extract could not be studied under these conditions because its
components were above the limit of detection at 280 nm. The rel-
ative percentages of phenolic compounds present in those extracts
are depicted in Table 1. Amongst the analysed samples, the acetone
and n-butanol extracts are those that showed the highest number
of phenolic compounds, 8 and 9, respectively, out of the 12 stan-
dards used. Vanillic acid was the major component of all extracts.
This phenolic acid has antisickling and anthelmintic activities and
suppressed hepatic ﬁbrosis in chronic liver injury (Itoh et al., 2010;
Khadem & Marles, 2010). Syringic acid, only present in the acetone
extract, is also known for its hepatoprotective effects (Itoh et al.,
2010) while gentisic acid, mainly present in the same extract,
has analgesic, anti-inﬂammatory, antirheumatic, and cytostatic
properties, inhibiting also low density lipoprotein oxidation and
the formation of cholesterol ester hydroperoxides in human plas-
ma (Ashidate et al., 2005). Gallic acid, present in all extracts, has
a variety of bioactivities, namely antineoplastic, bacteriostatic,
antimelanomagenic, antioxidant properties, and has been pro-
posed as candidate for the treatment of brain tumours (Lu et al.,
2010). Chlorogenic acid was found in the methanol and n-butanol
extracts and its protective effect against neurotoxocity reducingTable 1
Relative percentage of phenolics in Salvia sclareoides extracts evaluated by HPLC–DAD
at 280 nm.
Standards Rt (min) Extracts
MeOH EtOH BuOH Acetone
Gallic acid 1.189 0.8 0.8 1.2 1.7
(+)-Catechin 3.421 – – 0.5 –
Gentisic acid 4.085 – 1.0 – 3.6
Chlorogenic acid 4.346 1.1 – 1.3 –
Caffeic acid 5.085 – 0.8 1.4 2.4
Vanillic acid 5.551 2.5 1.3 2.8 6.9
Syringic acid 6.680 – – – 2.1
Coumaric acid 9.692 1.3 0.1 0.6 0.8
Ferulic acid 12.876 0.8 – 0.5 0.1
Rutin hydrate 25.104 – – – 1.6
Kaempferol O-glucoside 32.302 – – 0.7 –
Quercetin dehydrate 36.658 – – 1.4 –apoptosis induced by beta-amyloid (A beta) was recently reported
(Lee et al., 2011). In addition, it exhibits anticholinesterase and free
radical scavenging activities and may exert anti-amnesic activity
(Kwon et al., 2010). The antioxidant, anti-inﬂammatory and immu-
nostimulatory ferulic acid (Chao & Lin, 2011) promotes degenera-
tion of recombinant beta-amyloid peptide, as described by Picone
et al. (2009). Also caffeic acid has neuroprotective effects against
A beta-induced toxicity by the inhibition of calcium inﬂux and
tau phosphorylation (Sul et al., 2009), and protects neuronal cells
against oxidative stress induced cytotoxicity (Jeong et al., 2011).
Both caffeic and coumaric acids are capable of inducing neuropro-
tective effects in Parkinson’s disease (Vauzour, Corona, & Spencer,
2010) to a similar extent to that seen with the ﬂavonoids (+)-cate-
chin and quercetin, also present in the n-butanol extract (Martin,
Gonzalez-Burgos, Carretero, & Gomez-Serranillos, 2011). Not only
quercetin but also rutin, present in the acetone extract alone, are
known to revert cognitive deﬁcits (Tongjaroenbuangam et al.,
2011). Kaempferol O-glucoside also contributes to the nutraceuti-
cal relevance of this plant considering the wide range of pharmaco-
logical activities, including neuroprotective properties known for
kaempferol glycosides (Calderon-Montano, Burgos-Moron, Perez-
Guerrero, & Lopez-Lazaro, 2011).
Studies with animal models with a supplemented diet with
polyphenols have produced neuroprotection and favourable effects
concerning age-related cognitive and motor decline (Giacalone
et al., 2011). The present results reinforce the importance of S. scla-
reoides for its traditional use as food condiment and medicinal
plant, and as a source of functional food ingredients against neuro-
degenerative diseases.3.2. Antioxidant activity
3.2.1. DPPH radical scavenging activity
The antioxidant activity of S. sclareoides extracts was deter-
mined using the DPPH radical scavenging method (Table 2). The
n-butanol extract was the most bioactive with an IC50 = 7.9 lg/
ml. This extract was more active than the synthetic antioxidant
BHT (IC50 = 29.7 lg/ml) used as control, and showed an antioxidant
strength of the same order of magnitude as ascorbic acid, a natural
antioxidant (IC50 = 4.9 lg/ml). Methanol and ethanol extracts had
IC50 values of 114 and 134 lg/ml, respectively, while the water ex-
tract was the least active one, with a DPPH radical scavenging
activity (RSA) of 19.6% at 500 lg/ml (IC50 > 500 lg/ml).3.2.2. b-Carotene/linoleic acid bleaching assay
The antioxidant activity of the extracts was also assessed using
the b-carotene/linoleic acid method (Table 2). In this assay, the
acetone extract presented the highest activity (IC50 = 38.4 lg/ml),
which is of the same order of magnitude as that exhibited by ascor-
bic acid (IC50 = 26.1 lg/ml). Similar values were obtained for the n-
butanol, methanol, ethanol and water extracts. In contrast to the
relatively high antioxidant activity observed with the n-butanol
extract using the DPPH method, the capacity of this extract to in-
hibit b-carotene oxidation did not differ signiﬁcantly from that of
the other extracts.3.3. Acute cytotoxicity and genotoxicity
Acute toxicity and genotoxicity were assessed in vitro using
peripheral blood human lymphocytes and K562 human lympho-
blast immortalised cells. Cells tested with a ﬁnal extract concentra-
tion of up to 4 mg/ml showed no evidence of toxicity. The viability
of the cells was not affected and no evidence of genotoxic risk was
observed (Table 3).
Table 2
Antioxidant activity (%)a, IC50b and total phenolic contentc of Salvia sclareoides extracts.
Extract Method S. sclareoides extract concentration (lg/mL) IC50 (lg/mL) TPC (mg GAE/g dry extract)
1 3 5 10 50 100 500
Acetone DPPH <5 <5 <5 <5 6.1 ± 0.8 13.9 ± 1.2 30.5 ± 2.1 >500 67.0 ± 2.7
b-Carotene 6.9 ± 2.8 19.2 ± 4.4 39.6 ± 11.9 35.2 ± 3.4 51.6 ± 1.7 54.4 ± 2.3 80.8 ± 4.5 38.4
Butanol DPPH <5 6.1 ± 2.0 32.9 ± 2.4 53.9 ± 0.7 56.9 ± 4.0 58.7 ± 3.5 59.5 ± 2.9 7.9 379.4 ± 2.7
b-Carotene <5 25.2 ± 1.7 29.4 ± 3.9 32.4 ± 4.0 40.0 ± 3.4 54.0 ± 0.6 76.4 ± 1.7 57.6
Methanol DPPH <5 <5 <5 <5 5.3 ± 1.3 42.9 ± 3.9 47.7 ± 1.8 113.9 120.4 ± 2.7
b-Carotene <5 5.7 ± 11.1 19.3 ± 2.3 17.3 ± 0.6 53.9 ± 2.4 58.4 ± 5.7 76.1 ± 2.2 60.6
Ethanol DPPH <5 <5 <5 <5 6.6 ± 4.8 37.2 ± 4.8 40.9 ± 2.5 133.7 140.8 ± 4.7
b-Carotene <5 <5 16.5 ± 2.8 26.0 ± 2.8 37.6 ± 7.9 47.6 ± 0.6 81.2 ± 9.6 78.6
Water DPPH <5 <5 <5 <5 3.9 ± 6.2 13.7 ± 4.5 19.6 ± 4.1 >500 22.4 ± 0.7
b-Carotene <5 <5 9.7 ± 7.2 34.3 ± 0.7 52.4 ± 6.1 51.2 ± 4.2 65.1 ± 0.5 85.1
AA DPPH 3.0 ± 2.1 31.0 ± 2.9 48.5 ± 0.8 70.9 ± 1.5 72.8 ± 1.1 71.1 ± 2.1 73.1 ± 0.6 4.9 –
b-Carotene 23.1 ± 6.8 26.1 ± 8.2 32.1 ± 3.3 39.8 ± 2.3 61.6 ± 1.2 68.3 ± 6.8 71.8 ± 5.2 26.1
BHT DPPH <5 7.4 ± 1.8 9.6 ± 2.7 34.1 ± 2.7 59.8 ± 1.1 59.7 ± 0.7 61.3 ± 0.7 29.7 –
b-Carotene 44.6 ± 10.9 68.8 ± 0.0 81.2 ± 1.7 72.2 ± 0.9 86.0 ± 1.7 84.0 ± 1.1 92.7 ± 2.1 0.27
a Results of antioxidant activity in percentage are expressed as the average ± standard deviation of three replicates; AA (Ascorbic acid) and BHT (butylated hydroxytoluene)
are antioxidants used as controls for comparison purposes.
b IC50 is the concentration causing 50% antioxidant activity estimated by non-linear regression.
c Total phenol content, TPC, is expressed in mg of gallic acid equivalents (GAE) per g of dry Salvia extract.
Table 3
In vitro toxicity of Salvia sclareoides extracts: acute toxicity (4.0 mg/ml) in human
immortalised leukaemia cells (K562) and genotoxicity study (1.9 mg/ml) in human
peripheral blood lymphocytes.
S. sclareoides
extract
Acute toxicity Genotoxicity
Cellular viability
(percentage of blank)
Mitotic
index
Chromosomal
aberrations
Acetone – 10.50 ± 4.1 1.25 ± 1.3
Butanol 151.5 ± 52.6 10.25 ± 2.2 1.00 ± 1.2
Methanol 140.6 ± 68.2 n.d n.d.
Ethanol 105.2 ± 46.9 9.25 ± 3.8 0.75 ± 1.0
Water 79.3 ± 28.0 14.00 ± 3.7 1.00 ± 0.8
Controls
Blank 100 ± 37.5 12.75 ± 3.3 1.00 ± 0.8
H2O2 2% 34 ± 17.6 1.75 ± 1.0 5.00 ± 2.2
n.d. – not determined.
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In order to probe the relationship between S. sclareoides extracts
and prion propagation, we have investigated whether the extractsFig. 1. Structure of huPrP91–231 indicating residues affected by the butanol extract, w
attenuation, hence the magnitude of the effect. (For interpretation of the references to ccharacterised above display any speciﬁc interactions with the cel-
lular form of human prion protein (PrPC). PrPC is the substrate for
formation of the pathological form of the protein (PrPSc), and is a
candidate for anti-prion therapeutics (Mallucci & Collinge, 2005;
Nicoll, 2009). The stabilisation of the PrPC resulting from ligand
binding has the potential to inhibit or delay the pathological cas-
cade that is initiated by conformational change of the protein.
The effects of individual extracts on the NMR spectra of recom-
binant human prion protein (huPrP91–231) were probed using a
15N-HSQC-perturbation assay (Nicoll et al., 2010). Only the n-buta-
nol extract caused any perturbation of the protein resonances,
which manifested as an attenuation of speciﬁc resonances in the
spectrum (Fig. 1). The residues with affected resonances reside in
three separate regions of the protein: residues 93–112 (in the
unstructured N-terminal region of PrPC), 130–187 (comprising
the two strands of the beta sheet, helix 1 and the beginning of helix
2), and 205–225 in helix 3 at the C-terminus of the structured do-
main. Such attenuation of resonances is normally associated with
ligand exchange dynamics, and is commonly observed under
non-saturating conditions for ligands with dissociation constants
in the lM range. While the exact location of ligand binding is
not unambiguously determined by the measurements, there ishere the colour and thickness of the ribbon indicates increasing degree of signal
olour in this ﬁgure legend, the reader is referred to the web version of this article.)
A.P. Rauter et al. / Food Chemistry 132 (2012) 1930–1935 1935clearly some speciﬁc binding of components within the n-butanol
extract to PrPC and, most likely, associated changes in conforma-
tion in the folded domain and conformational restriction in the
N-terminal region.
4. Conclusion
The present study establishes S. sclareoides as a viable source of
functional food ingredients, due to its high antioxidant and radical
scavenging activities, as well as prion binding properties. The NMR
measurements showed that components extracted from S. sclareo-
ides had the capability to bind to the cellular form of human prion
protein in a speciﬁc manner, and hence provide the potential to
compete against the recruitment of prion protein into its patholog-
ical cascade. The active component(s) were present in the n-buta-
nol extract alone and binding caused conformational perturbation
in three separate regions of the protein, including the highly dy-
namic N-terminal region. The n-butanol extract is also the richest
one in phenolics, which are increasingly of interest in the food
industry, and shows promise for neurodegenerative diseases.
Furthermore, the tested extracts are neither cytotoxic nor genotoxic,
endorsing S. sclareoides as a promising plant for nutraceutical and
medicinal purposes.
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